Background: Neuroinflammation associated with Japanese encephalitis (JE) is mainly due to the activation of glial cells with subsequent release of proinflammatory mediators from them. The recognition of viral RNA, in part, by the pattern recognition receptor retinoic acid-inducible gene I (RIG-I) has been indicated to have a role in such processes. Even though neurons are also known to express this receptor, its role after JE virus (JEV) infections is yet to be elucidated.
Introduction
Japanese encephalitis (JE) is the cause of recurrent epidemic viral encephalitis in south-east Asia, with around 30,000-50,000 cases reported every year resulting in 10,000 to 15,000 deaths [1] . The JE virus (JEV) is a positive sense single stranded (ss) RNA virus, with approximately 11 kb genome. JEV is a neuroptropic virus that causes extensive neuronal death, which is reportedly mediated by activating the tumor necrosis factor receptor (TNFR)-1 complex [2] . One of the hallmarks of JEV infection is activation of microglia which is associated with increased cell-proliferation and bioactive/ inflammatory mediator production associated with distinct morphological changes. Although, certain activated glial-derived factors contribute to tissue repair, the interactive cross-talk between neuronal injury and microglial activation often determine the neuropathological outcome in JEV infection. The functional manifestations of such activated state are increased production of proinflammatory mediators like cyto/chemokines, reactive oxygen and nitrogen species by microglia. Increased release of proinflammatory mediators like tumor necrosis factor (TNF)-a, IL-1b, IL-6, MCP-1 and RANTES have been observed from microglia activated by JEV infection [3, 4, 5] . This release of cyto/chemokines represent the innate immune response against flaviviral infection of brain which in turn, is known to be mediated by the pattern recognition receptors (PRRs) such as toll like receptors (TLRs) and RIG-I-like receptors (RLRs) [6] .
RIG-I, a type of RLR, recognizes double-stranded (ds) RNA and uncapped 59 triphosphate RNA molecules, which are found in the genome of many RNA viruses or produced during viral replication. Interaction of viral RNA with RIG-I triggers several intracellular signaling pathways leading to activation of host cell cytokine gene expression and enhancement of other cellular functions. The pathway leading to activation of nuclear factor kB (NFkB) is activated by most, if not all, PRRs. NFkB plays a central role in driving the expression of proinflammatory mediators [7] . RIG-I has also been shown to activate p38MAPK, leading to secretion of CXCL-10, IL-12 and type-1 interferon in bone marrow-derived dendritic cells following viral infection [8] .
Although microglia and astrocytes are classically believed to be the predominant source of these mediators in the brain, neurons can also express these factors in disease settings [9, 10] . JEV tropism for neurons is a well established fact. Hence, it would be plausible to assume that the neuronal PRRs play a certain role in mediating the ultimate fate of the infected neurons. It has been reported in earlier studies that JEV is recognized by RIG-I in various cells of myeloid and non-immune lineage [11] ; but whether this is also true in neurons, is unknown. In recent years, the 'immune unresponsive' status of the CNS has been challenged by several studies. Apart from the glial cells, neurons have also been implicated to participate in innate immune defense against invading pathogens. The present investigation aims to determine whether viral recognition is RIG-I-dependent in neurons and also to evaluate role of the pathways downstream to RIG-I, in induction of proinflammatory mediators from JEV-infected mouse neurons. 
Methods

Ethics statement
Virus and cells
The GP78 strain of JEV was propagated in suckling BALB/c mice and their brains were harvested when pathological symptoms were observed. Virus titrations were conducted and quantified as described earlier [12] .
Mouse neuroblastoma Neuro2a (N2a) cells were obtained from National Centre for Cell Science, Pune, India. Cells were grown at 37uC in Dulbecco's modified Eagle medium (DMEM) supplemented with 3.7% sodium bi-carbonate (NaHCO 3 ), 10% fetal bovine serum and penicillin/streptomycin. All the reagents related to cell culture were obtained from Sigma (St. Louis, USA), unless otherwise stated.
Cortical neurons were cultured following published protocol [13] . Briefly, cortices of P2 BALB/c mouse pups were dissected aseptically in calcium-magnesium-free (CMF)-Tyrode solution following decapitation. The meninges were removed, tissue were chopped into smaller pieces and collected in CMF-Tyrode. These were treated with trypsin DNAse and then dissociated in the same solution by triturating to make a single cell suspension, pelleted and resuspended in Neurobasal media. Neurobasal media was supplemented with L-glutamine (2 mM), 30% glucose, 5% fetal calf serum, 10% horse serum and penicillin-streptomycin. Cells were plated at a density of 5610 3 cells/cm 2 onto poly-D-lysinecoated Labtek chamber slides and 96-well plate (Nunc, Roskilde, Denmark). After 48 h of incubation at 37uC, the serum containing medium was removed. Cells were incubated with serum free media for 4 h with antibiotics alone. For experimental treatments, the resting medium was exchanged for DMEM with N2 and B27 supplements, 25 mM KCl and antibiotics. Arabinoside (2610 25 M) was used for the inhibition of astrocyte multiplication.
Animal treatment
Five to six weeks old BALB/c mice of either sex were randomly distributed into 4 groups-Sham, JEV-infected, JEV-infected and treated with Vivo-morpholino against viral 39 conserved region (JEV+39 MO) and JEV-infected and treated with scrambled VivoMorpholino (JEV+S-MO). All Vivo-Morpholinos were commercially procured from Gene Tools LLC, (Philomath, OR, USA 
Infection and treatment schedule of neuronal cells
Cortical neurons were cultured in chamber slides in serum containing media, for 26 h. Cells were then either mock-infected or infected with JEV (2.3610 8 pfu/mL) at multiplicity of infection (MOI) of 5 for 1K h. Cells were then washed twice with sterile 16 PBS to remove non-internalized virus and were incubated for 24 h in serum free media.
N2a were plated and cultured in serum containing media until 70-80% confluency. Cells were transfected with either morpholino directed against RIG-I (r-MO; 59-AATTTCTTGGTTTCAATG-GGC-39) or a scrambled morpholino (Sc-MO; 59-GATAATTC-TGGTTTTAAATTC-39), at 10 mM concentrations along with specialized delivery moiety (endoporter) and incubated for 2 h at 37uC. These morpholinos and the endoporter were also procured from Gene Tools LLC, (Philomath, OR, USA). Post incubation, cells were infected with JEV as described above and were then reincubated with fresh morpholino-containing media for 24 h. Mock-infected cells with and without morpholino treatments served as controls; only JEV-infected cells, without morpholino treatment served as positive control.
Determination of cell viability
N2a was plated onto separate 96-well plates in triplicate followed by RIG-I ablation and JEV infection. Cell viability was assessed using CellTiter 96 AQueous One Solution Cell Proliferation Assay kit (Promega, USA) as described earlier [13] . 24 h post infection, 20 mL of MTS solution was added in each well. After 4 h incubation in dark, the absorbance, reflecting the reduction of MTS by viable cells was determined at 490 nm. Values were expressed as a percentage relative to those obtained in mockinfected cells.
Reactive oxygen species (ROS) generation assay
The level of intracellular ROS produced from different treatment groups were measured by the cell permeable, non-polar, H 2 O 2 -sensitive probe 5(and 6)-chlromethyl-20,70-dichlorodihydrofluoresceindiacetate (CM-H2DCFDA; Sigma, USA) as described earlier [13] with certain modifications. The mean fluorescence intensity was measured with the help of Varioskan Flash multimode reader (Thermo Electron, Finland) at excitation 500 nm and emission 530 nm. The fluorescence intensity of intracellular DCFDA is a linear indicator of the amount of H 2 O 2 produced in the cells. The measured mean fluorescence intensity was then normalized to equal concentrations of protein in each sample.
Cytokine bead array
Mouse cytokine bead array (CBA) kits (BD Biosciences, San Diego, CA) were used as per manufacturers' instructions to quantitatively measure cytokine levels in culture supernatants from all the treatment groups. Data were acquired using Cell Quest Pro Software in FACS Calibur and analyzed using BD CBA software (Becton Dickinson, San Diego, CA, USA) [13] .
Quantitative Real Time-PCR
Total cellular RNA from N2a treatment groups were extracted using Tri reagent (Sigma, USA). Random hexamer primers were used for cDNA synthesis using Advantage RT-PCR (Clontech, Mountain View, USA). cDNA were then subjected to mouse TLR signaling pathway PCR array (SA Biosciences, MD, USA) as per manufacturers instruction on a ABI Prism 7500 sequence detection system (Applied Biosystems, CA, USA). The real time PCR results were analyzed as per user manual guidelines and expressed as fold-changes over mockinfected.
Immunostaining
Mouse cortical neuronal cells were cultured in 4-well chamber slides and were either mock-infected or infected with JEV as described above. After 24 h of incubation, the cells were fixed in 4% paraformaldehyde and blocked with 5% BSA solution. The cells were then incubated overnight at 4uC with primary antibodies against RIG-I and NeuN (1:500; Chemicon, USA). Following incubation, the cells were washed and incubated with appropriate fluorochrome-conjugated secondary antibodies. After final washes cells were mounted with 49-6-diamidino-2-phenylindole (DAPI, Vector laboratories Inc., CA, USA).
N2a were cultured in 8-well chamber slides and were treated with morpholinos followed by infection with JEV, as described under section infection and treatment schedule. The cells were immunostained using primary antibodies against phosphoNFkB (1:250, Cell signaling, USA) and phosphoP38MAPK (1:250, Cell signaling, USA) as described above. The slides were observed under a Zeiss Axioplan 2 Fluorescence microscope and images were captured using the AxioVision Rel 4.6 software (Carl Zeiss, CA, USA).
Viral intracellular staining
N2a were plated in 60 mm culture plates and were treated as described above. After 24 h of incubation, cells were collected by washing with chilled sterile 16 PBS. After two washes with 16 PBS, cells were first fixed with BD cytofix solution (BD Biosciences) and permeabilized by resuspending in permeabilization buffer (BD Cytoperm plus; BD Biosciences). Cells were then washed twice in wash buffer (PBS containing 1% bovine serum albumin) and finally resuspended in wash buffer at 1610 6 cells per 100 mL. They were then treated with primary antibody (JEV Nakayama strain; Chemicon, USA; 1:100 dilutions) for 30 min at room temperature. Cells were then washed and pelleted by centrifugation followed by incubation with FITC-conjugated secondary antibody for 30 min. After final wash, cells were resuspended in 400 mL FACS buffer and analyzed on a FACS Calibur. The percentage of population of JEV-positive cells was calculated after gating the populations on a Dot plot using Cell Quest Pro Software (BD Biosciences).
Total cellular and nuclear protein extraction
N2a were seeded at a density of 5610 6 cell per 90-mm culture plates and were treated as described above. Mock-infected and treated N2a were collected using ice-cold 16 PBS. In order to obtain total cellular extracts, cells were lysed in buffer containing 1% Triton-X-100, 10 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.5% Nonidet P (NP-40), 1 mM EDTA, 0.2% EGTA, 0.2% sodium orthovanadate and protease inhibitor cocktail (Sigma, USA). To obtain nuclear extracts cells were washed twice with icecold PBS and pelleted. The cell pellet was resuspended in hypotonic buffer (10 mM HEPES, pH 8.0; 10 mM KCl; 5 mM dithiothreitol; 0.5 mM phenylmethylsulfonyl fluoride; 1 mM Na 3 VO 4 ) and incubated on ice for 15 min. Then the cells were lysed by the addition of 0.5% IGEPAL CA 630 and vigorous vortexing for 30 s. The nuclei were pelleted by centrifugation at 12,0006 g for 1 min at 4uC and resuspended in extraction buffer (20 mM HEPES, pH 8.0; 420 mM NaCl; 0.2 mM EDTA; 1 mM dithiothreitol; 0.5 mM phenylmethylsulfony fluoride; 1 mM Na 3 VO 4 ). After 15 min on ice, lysates were centrifuged at 12,0006 g for 10 min at 4uC [15] . Supernatants were collected and stored at 230uC. Protein levels were estimated by bicinchoninic assay (BCA) method.
Immunoblotting
Western blot analysis was performed to study modulation in expression of proteins post treatment, from total cellular or nuclear extracts, using primary antibodies against JEV NS5 (a kind gift from Dr. Chun-Jung Chen, Taichung Veterans General Hospital, Taichung, Taiwan), Caspase 8, C23, FADD, TRAF-6, (kind gifts from Dr. Ellora Sen, NBRC), IPS-1 (Sigma, USA), RIG-I, phospho IKKa/b, IkBa, phospho and total NFkB, and phospho and total p38MAP kinase (Cell Signalling, USA) at 1:1000 dilutions. After extensive washes with PBS-Tween, blots were incubated with appropriate peroxidase-conjugated secondary antibodies (Vector Laboratories, CA, USA). The blots were processed for development using chemiluminescence reagent (Millipore, USA). The images were captured and analyzed using Chemigenius, Bioimaging System (Syngene, Cambridge, UK). To determine equivalent loading of samples the blots were stripped and reprobed with anti-b-tubulin (Santa Cruz Biotechnology, CA, USA).
Statistical analysis
Data were compared between groups using one-tailed Student's T Test. Statistical significance was set at p,0.05 for all analyses.
Results
JEV causes upregulation of RIG-I both in vivo and in vitro
Immunohistochemical analysis of brain sections of Sham, JEV-infected and JEV+39 MO group of mice showed that there was prominent expression of RIG-I in JEV-infected group. However, viral inhibition by application of 39 MO resulted in RIG-I expression that was comparable to Sham (Fig. 1A) . Immunoblot analysis from whole brain lysates confirmed significant increase of RIG-I in JEV-infected or JEV+S-MO groups that was drastically reduced following treatment with 39 MO (p,0.05) (Fig. 1B&C) . RIG-I expression was also found to be enhanced following JEV infection in cultured primary cortical neurons (Fig. 1D) . Immunoblotting from N2a cells post 12 h and 24 h of infection showed significant increase in RIG-I, when compared to mock-infected cells. However, there was no significant difference in RIG-I levels between the two time points (Fig. 1E&G) . Application of rMO resulted in approximately 50% reduction in RIG-I level even after 24 h post JEV infection (p,0.05) (Fig. 1F&H) . JEV infection causes modulations in expressions of molecules downstream to RIG-I leading to activation of p38MAPK and NFkB Post JEV infection, the level of molecules associated with RIG-I signaling was investigated by immunoblotting. It was observed that the levels of IPS-1, TRAF 6 and active Caspase 8 were significantly increased both after 12 and 24 h post infection, whereas the levels of phosphoIKKa/b and FADD were only increased after 24 h (p,0.05). IkBa, phosphoNFkB and phosphoP38MAPK levels were found to be decreased significantly (p,0.05) after 24 h post infection compared to 12 h post infection groups (Fig. 2) . Following RIG-I inhibition, it was seen that phosphoIKKa/b, FADD, IPS-1, TRAF 6 and active Caspase 8 levels were significantly reduced 24 h post infection when compared to only JEV-infected or JEV+Sc-MO group (p,0.05) , while the level of IkBa was significantly increased (p,0.05) (Fig. 3) . Treatment of mock-infected cells with only rMO did not result in any significant change in the expression levels of these molecules (Fig. S1A-F) which shows that the changes were due to the virus infection. Immunocytochemical staining revealed increased expressions of phosphorylated form of NFkB and P38MAPK was expressed in higher degree 24 h post infection when compared to mock-infected cells. However, following rMO treatment, their levels were found to be comparable to mock-infected cells even after 24 h of JEV infection (Fig. 4A&B) . Immunoblotting from nuclear extracts of cells from all the treatment groups showed significantly increased levels of both phosphoNFkB and phosphoP38MAPK in JEV-infected and JEV+Sc-MO groups as compared to mock-infected (p,0.05). After RIG-I inhibition, their levels were found to be significantly decreased when compared to JEV-infected group (p,0.05) (Fig. 4C-E) .
Transcriptional alterations of certain signaling molecules associated with RIG-I following JEV infection
Quantitative real time PCR was carried out to determine the transcriptional changes in certain effectors and downstream target genes associated with RIG-I. Specifically, the expression of effector molecules such as Caspase 8, FADD, IRAK 1 and TRAF 6 were found to be significantly increased following JEV infection. Among the downstream target genes, the levels of MCP-1, CXCL-10, CHUK, GMCSF, IL-6, IL-2, CLEC4E, IL6Ra, NFkB-1 and Rel were also found to be significantly increased. On ablating RIG-I with the application of rMO, it was found that there was significant decrease in all the studied effector molecules. Amongst the studied downstream molecules all, except NFkB-1, IL-6Ra and IL-2, showed significant decreases when compared to JEV-infected group (p,0.05). IL-2 level was found to be significantly increased after rMO treatment (p,0.05) (Fig. 5) .
Ablation of RIG-I abrogates secretion of proinflammatory cyto/chemokines from neurons following JEV infection
The release of proinflammatory cyto/chemokines viz. IL-12, TNF-a, MCP-1 and IL-6, were found to be significantly elevated both 12 and 24 h post JEV infection when compared to that from respective time-matched mock-infected cells (p,0.05) (Fig. 6A-D) . However, ablation of RIG-I resulted in significant reduction in their levels 24 h post infection with JEV when compared to only JEV-infected or JEV+Sc-MO group (p,0.05) (Fig. 7A-D) . rMO itself did not cause appreciable change in cytokine levels (Fig. S1G-J) . 
RIG-I ablation results in increased viral load, decreased survivability and generation of oxidative stress in N2a
Flow cytometric analysis showed increased presence of viral antigen after intracellular staining in JEV+rMO group when compared to JEV-infected or JEV+Sc-MO groups (Fig. 8A) . Immunoblot analysis of viral NS5 also showed significant increase in JEV+rMO group when compared to JEV-infected or JEV+Sc-MO groups (p,0.05) (Fig. 8B&C) . MTS assay performed on all treatment groups showed reduced survivability in JEV-infected or JEV+Sc-MO groups when compared to mock-infected, though the change was not statistically significant. However, in the JEV+rMO group survivability was significantly decreased when compared to mock-infected, JEV-infected or JEV+Sc-MO groups (p,0.05) (Fig. 8D) . Generation of oxidative stress is a hallmark of JEVinfected cells. Here, we found that ROS levels were significantly increased in JEV-infected or JEV+Sc-MO groups when compared to mock-infected groups. However, in JEV+rMO group, the ROS level was found to be even higher than either JEV-infected or JEV+Sc-MO groups (p,0.05) (Fig. 8E) .
Discussion
Multiple cell types in the body have been reported to be capable of sensing flaviviral infections and initiating innate immune responses. Double stranded (ds)RNA, generated during infection as a replication intermediate for RNA viruses, serve as pathogenassociated molecular pattern that can be recognized by several PRRs. RIG-I, a cytoplasmic protein that has been shown to be a detector of dsRNA as well as ssRNA with 59 triphosphates [16] . Recognition of flaviviruses through RIG-I has been reported [17] that results in type I interferon and proinflammatory cyto/ chemokine production from cells of the myeloid lineage [18] . In vitro studies have also shown that cells of non-immune lineage primarily respond to intracellular accumulation of viral dsRNA via RIG-I [19] . Specifically, RIG-I has been shown to be essential in the identification of JEV for the production of type I interferon in Vero (epithelial) cells [20] .
The innate immune responses of neurons following JEV infection is poorly understood as the CNS has for long, been considered as an 'immune privileged' organ. It has been reported that PRRs are expressed in neurons [21] . RIG-I is basally expressed in undetectable levels in uninfected neurons [22] , though recent studies suggest that it plays a prominent role in mediating innate immune response, following viral infections [23] . In this study, prior to JEV infection, we found very low expression of RIG-I both in whole brain and in cultured neurons. JEV predominantly infects neurons, following which RIG-I was found to be expressed in significantly higher levels in brain. As after inhibiting the virus using an antisense molecule (39 MO) no significant alteration in RIG-I expression was observed from non-infected brain samples, it can be safely assumed that JEV causes upregulation of this PRR in various CNS cell types, including neurons. Upon recognition of viral RNA, the caspase recruitment domain (CARD)-like motif of RIG-I gets activated and interacts with interferon promoter stimulator-1 (IPS-1) to relay the signal. The signal is divided at IPS-1, resulting in activation of NFkB and IRF-3 and -7 [7] . Post JEV infection, IPS-1 expression was found to be moderately increased that led to dramatic increase of the adaptor molecule FADD. Apart from its role in apoptotic process, FADD is also known to activate TNF receptor-associated factor 6 (TRAF 6), which was found to be increased following JEV infection in neurons. TRAF 6 activates IkB kinase a/b (IKKa/b) via Tak1 leading to phosphorylation of IkBa-NFkB complex. JEV infection leads to decreased level of IkBa, at later time point indicating its dissociation from the complex followed by proteolytic degradation. Since the removal of the inhibitory effect of IkBa, NFkB is activated and translocated into the nucleus to modulate the expression of proinflammatory cyto/chemokine genes. We found increased level of phospho NFkB in neuronal cells following JEV infection. Its level in nuclear extract of these cells was also increased. Activation of p38MAPK has been shown to be associated with the activation of RIG-I via TRAF 2-TAK 1 dependent pathway [8] in non-neuronal cells. Whether this also occurs in neurons was previously unknown. Here we have shown for the first time that following JEV infection, phospho p38MAPK levels are significantly increased in neurons as evident from immunocytochemical observations and also from immunoblot analysis of nuclear extracts obtained from infected cells. Both NFkB and p38MAPK are well known stimulators of proinflammatory cyto/chemokine gene expression, and their upregulation was concurrent with elevated secretions of IL-12, TNF-a, MCP-1 and IL-6 and increased expression of CXCL-10 (IP-10), GMCSF from infected neuronal cells. RIG-I inhibition carried out by transfecting cells with rMO resulted in downregulation of phosphoIKKab, TRAF 6, IPS-1, FADD, and active Caspase 8, except IkBa, which showed significant increase indicating its inhibitory effects on NFkB. Subsequently, it was observed that phospho NFkB and phospho p38MAPK levels were decreased that led to reduction in the levels of the proinflammatory mediators.
An interesting observation was that neuronal survivability was negatively affected following RIG-I inhibition. JEV-infection results in development of oxidative stress and leads to apoptotic death of neuronal cell lines [24] . Ablation of RIG-I was found to be associated with decreased survivability and increased stress in the cells in comparison to only JEV infected cells. This was concomitant with increased intracellular viral load, as shown by immunoblot and flow cytometric analysis. This phenomenon may be due to the fact the antiviral innate immune response is subverted following RIG-I ablation and this observation merits further studies. Thus, it is clear from this study that viral sensing through RIG-I lead to modulations in the downstream pathway (Fig. 9 ) that cause the infected neurons to participate in the inflammatory milieu in CNS which ultimately leads to their own demise. However, the concerted role of other PRRs cannot be ruled out at this point of time. Since there are other sensors present in cells such as TLRs, PKR, MDA5 and MPYS, a co- Figure S1 The antisense rMO treatment of mockinfected cells does not result in modulation of downstream signaling molecules or proinflammatory cyto/ chemokine release. On application of rMO to mock-infected cells, the expression levels of TRAF6, IPS-1, active Caspase 8, IkBa and FADD were found not to be significantly different from that observed in only mock-infected cells (A-F). To check whether rMO induced proinflammatory cytochemokine release from cells, CBA was performed from culture supernatants. Results showed that there were no significant differences between the cyto/chemokine levels in mock-infected and mock-infected+rMO treated groups (G-J). Data is representative of 2 independent experiments. (TIF)
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